Roivant Sciences

Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases

placeNew York City, New York, United States calendar_todayFounded 2014 groups662 employees language roivant.com

Registered entities

Innovation

11 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 958 times.

YearFilings
20183
20195
20203
20215
20221
20231

Investor mix

10 investors on record; lead investors include NovaQuest Capital Management, SoftBank Vision Fund; 1 has since exited.

Investor typeCountShare
Venture capital440%
Private equity440%
Other / undisclosed220%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

15 May 2026 · People Operations Associate · New York

21 Nov 2025 · Accounts Payable Specialist · New York

31 Oct 2025 · Service Desk Lead · New York

30 May 2025 · Manager, Statistical Programming · Jersey City

Based on job postings tracked across public sources.

Coming soon